(Q37489881)

20 August 2017

1 reference

title

Adoptive T cell immunotherapy for cytomegalovirus (English)

1 reference

20 August 2017

0 references

1 reference

Karl S Peggs

1

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

Expert Opinion on Biological Therapy

20 August 2017

published in

1 reference

20 August 2017

volume

9

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

725-736

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

20 August 2017

1 reference

Cytomegalovirus and human immunosenescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Vaccine prevention of maternal cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

Cytomegalovirus‐Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell Transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590902967588

10.1517/14712590902967588

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference